Chula Pharmacy prepares to test “Baiya Vaccine” a Thai vaccine against COVID-19 by “Baiya Phytofarm”, a Chula startup. The vaccines have been produced at the first plant in Asia that manufactures plant-based vaccines for humans. Clinical trials with volunteers and the research for the second-generation vaccine to fight the virus variants are to commence in September 2021.

According to Chula researchers the volume of online gambling has soared during the COVID-19 pandemic, posing a serious threat to minors, and the government should urgently tackle this problem.

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

The COVID-19 outbreaks in Thailand have seen an ever-increasing number of infections as new clusters are emerging. The faculty members of Sasin School of Management — Prof. Dr. Kua Wongboonsin, Asst. Prof. Dr. Piyachart Phiromswad, Assoc. Prof. Dr. Pattanaporn Chatjuthamard, Asst. Prof. Dr. Pattarake Sarajoti, and Asst. Prof. Dr. Sabin Srivannaboon, with financial support from the National Research Council of Thailand (NRCT), jointly present ways to reduce the spread of COVID-19 sustainably in a study to identify technologies that can instantly and appropriately help professionals who find social distancing difficult.

Chula’s Faculty of Engineering joins hands with PTT to develop a 2 in1 face mask, an innovation that protects against PM2.5 dust particles and COVID-19 virus that can be reused more than 15 times, helps reduce waste, is pollution-free, and will be available for sale soon.

Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus. They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.